Company Research Report: ProPharma

Company Overview

Name: ProPharma Group MIS Limited

• Mission: To enable clients to excel at every stage of the pharmaceutical lifecycle by co-creating optimal solutions, building sustainable and scalable operating models, developing auxiliary capabilities, and positioning clients for development and growth.

• Founded: ProPharma was established in 2001.

• Key People:

• Dawn Sherman - Chief Executive Officer

• Jason DeGoes - President

• Brian Tuttle - Chief Financial Officer

• Rachel Bias - Chief Human Resources Officer

• Kirk Wroblewski - Chief Information Officer

• Zosya Popik - Chief Marketing Officer

• Sara Sorrentino - Chief Business Development Officer

• Matthew Dube - President, R&D Technology

• Laura Hopper - President, Pharmacovigilance

• Rajul Jain - President, Medical Information

• Jim Kolbet - President, Quality and Compliance

• Matthew Weinberg - President, Regulatory Sciences

• Kevin Wysocki - President, Clinical Research Solutions

• Vicki Gashwiler - Global Head of MedTech

• Headquarters: Raleigh, NC, USA

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: ProPharma is recognized as the world’s largest Research Consulting Organization (RCO), providing an extensive array of consulting services across the full product lifecycle for pharmaceutical, biotechnology, and medical device industries.

Products

ProPharma provides multiple solutions and services across the product lifecycle:

• Regulatory Sciences: Support across the full lifecycle for drugs, biologics, medical devices, and diagnostics.

• Clinical Research Solutions: Multiphase clinical development and study execution focused on drugs, biologics, medical devices, and diagnostics.

• R&D Technology: Technology solutions that enable products to get to market quickly and efficiently.

• Quality & Compliance: Maintenance of quality and compliance standards necessary for product market entry.

• Pharmacovigilance: Ensured safety and consistency from clinical development through post-approval.

• Medical Information: Comprehensive medical information services including integrated contact centers available 24/7/365.

Key Features:

• Bespoke/Custom Solutions: Tailored solutions delivered through a scalable operating model that can adapt to client needs.

• End-to-End Support: Full support across the entire product lifecycle.

• Deep Domain Expertise: Utilizes specialized subject matter experts across therapeutic areas and specialties.

Recent Developments

• New Products/Services & Features:

• ProPharma launched an innovative Cell & Gene Therapy Manufacturing Platform, a first-of-its-kind Cell Factory Box to streamline production.

• Awards:

• ProPharma received several prestigious awards in 2024 including the CRO Leadership Award and the CPHI Regulatory and Compliance Award.

• Leadership Changes:

• Recent appointments include Brian Tuttle as Chief Financial Officer and Vicki Gashwiler as Vice President of Clinical Operations, Medical Technology.

• Dawn Sherman was named Chief Executive Officer, bringing significant experience from the life sciences and biopharmaceutical industry.

• Strategic Partnerships:

• ProPharma continued its collaboration with prominent pharmaceutical companies, playing a crucial role in the AstraZeneca vaccine project by assessing the quality of approximately 500 million doses.

This report reflects ProPharma’s current operational landscape and recent activities without additional commentary.